Related references
Note: Only part of the references are listed.Transcriptomic and Proteomic Analyses Reveal the Potential Mode of Action of Chondrocyte Sheets in Hyaline Cartilage Regeneration
Eriko Toyoda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice
K. M-C Lee et al.
OSTEOARTHRITIS AND CARTILAGE (2020)
Interleukin-34 overexpression mediated through tumor necrosis factor-alpha reflects severity of synovitis in knee osteoarthritis
Wanvisa Udomsinprasert et al.
SCIENTIFIC REPORTS (2020)
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo
Claudia Mugnaini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Alterations in Anandamide Synthesis and Degradation during Osteoarthritis Progression in an Animal Model
Marta Bryk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain
Shouan Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The Pharmacology of Pain Associated With the Monoiodoacetate Model of Osteoarthritis
Joao de Sousa Valente
FRONTIERS IN PHARMACOLOGY (2019)
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis
Jakub Mlost et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Regulation of Osteoclast Differentiation by Cytokine Networks
Dulshara Sachini Amarasekara et al.
IMMUNE NETWORK (2018)
Interleukin-34 Synovial Fluid Was Associated with Knee Osteoarthritis Severity: A Cross-Sectional Study in Knee Osteoarthritis Patients in Different Radiographic Stages
Shuang-Lei Wang et al.
DISEASE MARKERS (2018)
Changes in Monoaminergic Neurotransmission in an Animal Model of Osteoarthritis: The Role of Endocannabinoid Signaling
Jakub Mlost et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
CCL17 blockade as a therapy for osteoarthritis pain and disease
Ming-Chin Lee et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes
Henrik Lofvall et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
Augustin Latourte et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
HIGH SYNOVIAL FLUID INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH INCREASED MATRIX METALLOPROTEINASE LEVELS AND SEVERE RADIOGRAPHIC CHANGES IN OSTEOARTHRITIS PATIENTS
K. Vuolteenaho et al.
OSTEOARTHRITIS AND CARTILAGE (2017)
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt et al.
NATURE COMMUNICATIONS (2017)
Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation
A. Bertuglia et al.
OSTEOARTHRITIS AND CARTILAGE (2016)
High MMP-1, MMP-2, and MMP-9 protein levels in osteoarthritis
G. Q. Zeng et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Correlation between interleukin-6 expression in articular cartilage bone and osteoarthritis
X. Q. Qu et al.
GENETICS AND MOLECULAR RESEARCH (2015)
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice
A. Sophocleous et al.
OSTEOARTHRITIS AND CARTILAGE (2015)
A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis
Natalia Malek et al.
PAIN (2015)
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
Carmen La Porta et al.
PAIN (2015)
Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis
Anneloes van Walsem et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Reduction in Disease Progression by Inhibition of Transforming Growth Factor α-CCL2 Signaling in Experimental Posttraumatic Osteoarthritis
C. Thomas G. Appleton et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis
Yuan-kun Xu et al.
BIOLOGICAL RESEARCH (2015)
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
Marita Cross et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Prediction of Young's modulus of trabeculae in microscale using macro-scale's relationships between bone density and mechanical properties
Lukasz Cyganik et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2014)
Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes
S. L. Dunn et al.
OSTEOARTHRITIS AND CARTILAGE (2014)
Neuropathic pain in osteoarthritis: A review of pathophysiological mechanisms and implications for treatment
Theodoros Dimitroulas et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Immunopathogenesis of osteoarthritis
Abdul Haseeb et al.
CLINICAL IMMUNOLOGY (2013)
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate
Carmen La Porta et al.
PAIN (2013)
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint
James J. Burston et al.
PLOS ONE (2013)
Selection of Suitable Reference Genes for Normalization of Quantitative Real-Time PCR in Cartilage Tissue Injury and Repair in Rabbits
Xiao-Xiang Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Dose-Dependent Expression of Neuronal Injury Markers during Experimental Osteoarthritis Induced by Monoiodoacetate in the Rat
Joana Ferreira-Gomes et al.
Molecular Pain (2012)
State of the Art Treatments for Cannabis Dependence
Itai Danovitch et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation
Antonia Sophocleous et al.
ENDOCRINOLOGY (2011)
Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis
J. M. Hoch et al.
OSTEOARTHRITIS AND CARTILAGE (2011)
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis
Niklas Schuelert et al.
PAIN (2011)
Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants
Dorothea Piecha et al.
INFLAMMATION RESEARCH (2010)
Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis
C. Karlsson et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo
Clifton O. Bingham et al.
RHEUMATOLOGY (2009)
Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage
Manuel Pombo-Suarez et al.
BMC MOLECULAR BIOLOGY (2008)
High levels of synovial fluid osteoprotegenin (OPG) and increased serum ratio of receptor activator of nuclear factor-κB ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis
Anastasia Pilichou et al.
CLINICAL BIOCHEMISTRY (2008)
Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees
Niklas Schuelert et al.
ARTHRITIS AND RHEUMATISM (2008)
Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro
Maarit Kellinsalmi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Pressure application measurement (PAM): A novel behavioural technique for measuring hypersensitivity in a rat model of joint pain
Nicola J. Barton et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Cannabinoid pharmacology: the first 66 years
RG Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cross-talk between the interleukin-6 and prostaglandin E2 signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-κB (RANK) ligand/RANK system
XH Liu et al.
ENDOCRINOLOGY (2005)
Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis
M Sabatini et al.
ARTHRITIS AND RHEUMATISM (2005)
Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice
EJ Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats
R Renkiewicz et al.
ARTHRITIS AND RHEUMATISM (2003)
COX-2 selective NSAID decreases bone ingrowth in vivo
S Goodman et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2002)
Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism
R Gruber et al.
BONE (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
D Bridges et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
